Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$3.42
0.113.32%
À la fermeture: -
$3.45
0.030.87%
Après les heures de négociation: 7:54 PM EDT
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
Petco Health and Wellness Co Inc a un objectif de cours consensus de $4.18, basé sur les évaluations des 16 analystes. Le plus élevé est de $10 attribué par Gordon Haskett le avril 28, 2023, et le plus bas est de $1.5 attribué par B of A Securities le avril 2, 2024. Les 3 dernières évaluations d'analystes ont été publiées par RBC Capital, Jefferies et UBS le septembre 3, 2025, août 29, 2025 et août 29, 2025. Avec un objectif de cours moyen de $3.95 entre RBC Capital, Jefferies et UBS, il y a une variation implicite de 14.50% upside pour Petco Health and Wellness Co Inc à partir de ces dernières évaluations d'analystes.
Sociétés d'analyse émettant des recommandations1
RBC Capital
Jefferies
UBS
Wells Fargo
Baird
1calculé à partir des notes des analystes
Notes d'analystes pour Petco Health and Wellness
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
09/03/2025 | 15.95% | RBC Capital | $4 → $4 | Reiterates | Outperform → Outperform | |||
09/02/2025 | — | Guggenheim | — | Reiterates | Neutral → Neutral | |||
08/29/2025 | 20.29% | Jefferies | $4.05 → $4.15 | Maintains | Hold | |||
08/29/2025 | 7.25% | UBS | $3.25 → $3.7 | Maintains | Neutral | |||
08/29/2025 | 15.95% | Wells Fargo | $3.5 → $4 | Maintains | Equal-Weight | |||
08/29/2025 | 15.95% | Baird | $3.5 → $4 | Maintains | Neutral | |||
06/06/2025 | 30.44% | Morgan Stanley | $5 → $4.5 | Maintains | Equal-Weight | |||
06/06/2025 | 1.45% | Wells Fargo | $3 → $3.5 | Maintains | Equal-Weight | |||
03/27/2025 | 29.86% | Goldman Sachs | $4 → $4.48 | Maintains | Buy | |||
03/27/2025 | -5.79% | UBS | $5.5 → $3.25 | Maintains | Neutral | |||
03/27/2025 | 15.95% | RBC Capital | $6 → $4 | Maintains | Outperform | |||
03/27/2025 | 15.95% | Wedbush | $6 → $4 | Maintains | Outperform | |||
03/27/2025 | 1.45% | Baird | $5 → $3.5 | Maintains | Neutral | |||
03/18/2025 | -20.29% | Citigroup | $5 → $2.75 | Maintains | Neutral | |||
02/24/2025 | -13.04% | Wells Fargo | $5 → $3 | Maintains | Equal-Weight | |||
01/21/2025 | 44.93% | Morgan Stanley | $6 → $5 | Maintains | Equal-Weight | |||
12/20/2024 | 73.92% | RBC Capital | $6 → $6 | Reiterates | Outperform → Outperform | |||
12/06/2024 | 73.92% | Wedbush | $5.5 → $6 | Maintains | Outperform | |||
12/06/2024 | 73.92% | Morgan Stanley | $3 → $6 | Maintains | Equal-Weight | |||
12/06/2024 | 73.92% | RBC Capital | $5 → $6 | Maintains | Outperform | |||
12/06/2024 | 44.93% | Wells Fargo | $3 → $5 | Maintains | Equal-Weight | |||
10/18/2024 | 59.42% | Wedbush | $5 → $5.5 | Maintains | Outperform | |||
09/12/2024 | 30.44% | Citigroup | $4 → $4.5 | Maintains | Neutral | |||
09/12/2024 | 15.95% | Goldman Sachs | $5 → $4 | Maintains | Buy | |||
09/11/2024 | 1.45% | RBC Capital | $3 → $3.5 | Maintains | Outperform | |||
09/11/2024 | -13.04% | Wells Fargo | $2.75 → $3 | Maintains | Equal-Weight | |||
09/11/2024 | 44.93% | Wedbush | $5 → $5 | Reiterates | Outperform → Outperform | |||
07/19/2024 | 15.95% | Citigroup | $3 → $4 | Maintains | Neutral | |||
07/18/2024 | 44.93% | Wedbush | $4 → $5 | Maintains | Outperform | |||
05/29/2024 | 15.95% | Wedbush | $4 → $4 | Reiterates | Outperform → Outperform | |||
05/24/2024 | -13.04% | RBC Capital | $2.7 → $3 | Maintains | Outperform | |||
05/23/2024 | 44.93% | Needham | $5 → $5 | Reiterates | Buy → Buy | |||
05/23/2024 | 15.95% | Wedbush | $3 → $4 | Maintains | Outperform | |||
05/23/2024 | -5.79% | UBS | $2.5 → $3.25 | Maintains | Neutral | |||
05/07/2024 | -49.27% | Citigroup | $2.85 → $1.75 | Maintains | Neutral | |||
04/02/2024 | -56.52% | B of A Securities | $5 → $1.5 | Downgrade | Buy → Underperform | |||
03/25/2024 | -42.03% | Wells Fargo | $3 → $2 | Maintains | Equal-Weight | |||
03/20/2024 | -27.53% | UBS | $3 → $2.5 | Maintains | Neutral | |||
03/15/2024 | -21.74% | RBC Capital | $3.5 → $2.7 | Maintains | Outperform | |||
03/15/2024 | -13.04% | Evercore ISI Group | $4 → $3 | Maintains | In-Line | |||
03/14/2024 | -27.53% | Baird | $3 → $2.5 | Maintains | Neutral | |||
03/13/2024 | 44.93% | Needham | $5 → $5 | Maintains | Buy | |||
12/19/2023 | -9.85% | Jefferies | → $3.11 | Initiates | → Hold | |||
12/04/2023 | -13.04% | Morgan Stanley | $5 → $3 | Maintains | Equal-Weight | |||
12/04/2023 | 1.45% | RBC Capital | $7 → $3.5 | Maintains | Outperform | |||
11/30/2023 | 44.93% | Goldman Sachs | $7 → $5 | Maintains | Buy | |||
11/30/2023 | 1.45% | Wedbush | $4.5 → $3.5 | Maintains | Outperform | |||
11/29/2023 | 44.93% | Needham | $8 → $5 | Maintains | Buy | |||
11/29/2023 | — | Wells Fargo | — | Downgrade | Overweight → Equal-Weight | |||
10/31/2023 | 30.44% | Wedbush | $6 → $4.5 | Maintains | Outperform | |||
09/29/2023 | — | Wolfe Research | — | Initiates | → Peer Perform | |||
09/08/2023 | 131.89% | Evercore ISI Group | $6 → $8 | Maintains | In-Line | |||
08/25/2023 | 189.86% | B of A Securities | $12 → $10 | Maintains | Buy | |||
08/25/2023 | 44.93% | Morgan Stanley | $9 → $5 | Maintains | Equal-Weight | |||
08/25/2023 | 102.9% | RBC Capital | $10 → $7 | Maintains | Outperform | |||
08/25/2023 | 73.92% | Wedbush | $9 → $6 | Maintains | Outperform | |||
08/25/2023 | 102.9% | Wells Fargo | $11 → $7 | Maintains | Overweight | |||
08/25/2023 | 131.89% | Needham | $12 → $8 | Maintains | Buy | |||
08/16/2023 | 160.88% | Wedbush | $10 → $9 | Maintains | Outperform | |||
05/26/2023 | 247.84% | B of A Securities | $14.5 → $12 | Maintains | Buy | |||
05/26/2023 | 189.86% | RBC Capital | → $10 | Reiterates | Outperform → Outperform | |||
05/25/2023 | 160.88% | Morgan Stanley | $10 → $9 | Maintains | Equal-Weight | |||
05/24/2023 | 247.84% | Needham | $15 → $12 | Maintains | Buy | |||
05/22/2023 | 218.85% | Wedbush | → $11 | Reiterates | Outperform → Outperform | |||
04/28/2023 | 189.86% | Gordon Haskett | → $10 | Initiates | → Hold | |||
04/14/2023 | 334.8% | Needham | $20 → $15 | Maintains | Buy | |||
03/29/2023 | 320.3% | B of A Securities | $18 → $14.5 | Maintains | Buy | |||
03/28/2023 | 146.38% | Citigroup | $11 → $8.5 | Maintains | Neutral | |||
03/23/2023 | 189.86% | Evercore ISI Group | $12 → $10 | Maintains | In-Line | |||
03/23/2023 | 189.86% | RBC Capital | $14 → $10 | Maintains | Outperform | |||
03/23/2023 | 189.86% | Morgan Stanley | $12 → $10 | Maintains | Equal-Weight | |||
03/23/2023 | 218.85% | Baird | $14 → $11 | Maintains | Outperform | |||
03/23/2023 | 479.73% | Needham | → $20 | Reiterates | → Buy | |||
03/15/2023 | 247.84% | Wells Fargo | $14 → $12 | Maintains | Overweight | |||
03/13/2023 | 218.85% | Citigroup | → $11 | Downgrade | Buy → Neutral | |||
02/09/2023 | 305.81% | RBC Capital | → $14 | Reiterates | → Outperform | |||
01/17/2023 | 247.84% | Morgan Stanley | $14 → $12 | Maintains | Equal-Weight | |||
12/02/2022 | 305.81% | Morgan Stanley | $19 → $14 | Maintains | Equal-Weight | |||
12/01/2022 | 363.78% | Goldman Sachs | $18 → $16 | Maintains | Buy | |||
12/01/2022 | 363.78% | RBC Capital | $17 → $16 | Maintains | Outperform | |||
12/01/2022 | 247.84% | UBS | $16 → $12 | Maintains | Neutral | |||
11/28/2022 | 479.73% | Needham | $30 → $20 | Maintains | Buy | |||
11/18/2022 | 305.81% | Wells Fargo | $19 → $14 | Maintains | Overweight | |||
10/19/2022 | 247.84% | Evercore ISI Group | $15 → $12 | Downgrade | Outperform → In-Line | |||
10/04/2022 | 421.75% | Goldman Sachs | $20 → $18 | Maintains | Buy | |||
09/26/2022 | 450.74% | Wells Fargo | $22 → $19 | Maintains | Overweight | |||
09/07/2022 | 392.77% | RBC Capital | → $17 | Initiates | → Outperform |
FAQ
Quel est le cours indicatif de l'action Petco Health and Wellness (WOOF) ?
Le dernier objectif de prix pour Petco Health and Wellness (NASDAQ:WOOF) a été rapporté par RBC Capital le septembre 3, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $4.00 s'attendant à ce que WOOF se rise dans les 12 prochains mois (un possible changement de 15.95% upside). 27 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour Petco Health and Wellness (WOOF) ?
La dernière note d'analyste pour Petco Health and Wellness (NASDAQ:WOOF) a été fournie par RBC Capital, et Petco Health and Wellness réitéré leur note outperform.
Quand a eu lieu la dernière mise à niveau pour Petco Health and Wellness (WOOF) ?
Il n'y a pas de dernière amélioration pour Petco Health and Wellness
Quand a eu lieu la dernière dégradation pour Petco Health and Wellness (WOOF) ?
La dernière réduction pour Petco Health and Wellness Co Inc a eu lieu le avril 2, 2024 lorsque B of A Securities a changé leur objectif de prix de $5 à $1.5 pour Petco Health and Wellness Co Inc.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour Petco Health and Wellness (WOOF) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Petco Health and Wellness, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Petco Health and Wellness a été déposée le septembre 3, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers septembre 3, 2026.
La note d'analyste pour Petco Health and Wellness (WOOF) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de Petco Health and Wellness (WOOF) était un réitéré avec un objectif de prix de $4.00 à $4.00. Le prix actuel de Petco Health and Wellness (WOOF) est de $3.45, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.